Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2008
10/01/2008EP1689355A4 Selective inhibitors of nuclear factor-kb activation and uses thereof
10/01/2008EP1673077B1 Pharmaceutical compositions comprising malonamide derivatives for decreasing sebum production
10/01/2008EP1646364B1 Hfc solution formulations containing an anticholinergic
10/01/2008EP1641454B1 Pyrazolo[3,4-b]pyridin-6-ones as gsk-3 inhibitors
10/01/2008EP1635825B1 Synergistic combinations including n-acylated 4-hydroxyphenylamine derivatives and caffeine
10/01/2008EP1635808B1 Topical use of valproic acid for the prevention or treatment of psoriasis and acne
10/01/2008EP1626710B1 Use of 2,2,3,3, tetramethylcyclopropane carboxylic acid derivatives for treating psychiatric disorders
10/01/2008EP1622903B1 Cannabinoid receptor ligands and uses thereof
10/01/2008EP1608377B1 Pharmaceutical compositions comprising inhibitors of fab i and further antibiotics
10/01/2008EP1608368B1 Pharmaceutical compositions comprising a combination of rapamycin or its derivative and pimecrolimus for the treatment of inflammatory bowel disease (ibd)
10/01/2008EP1587522B1 Attaining sexual wellness and health of the sexual vascular system with proanthocyanidins
10/01/2008EP1585523B1 Use of purine derivatives for inducing differentiation of supernumerary hair cells and deiters' cells in the developing organ of corti for treating deafness
10/01/2008EP1565456B1 1,2,4-triazole derivative, method for preparing the same, and pharmaceutical composition containing the same
10/01/2008EP1515717B1 Calcium salts of indole derived statins
10/01/2008EP1496877B1 Method and composition for treatment of diabetes, hypertension, chronic heart failure and fluid retentive states
10/01/2008EP1420780B1 Cyclopropyl and cyclobutyl epothilone analogs
10/01/2008EP1399424B8 Method for preparation of 10,11-dihydro-10-hydroxy-5h-dibenz/b,f/azepine-5-carboxamide and 10,11-dihydro-10-0x0-5h-dibenz/b,f/azepine-5-carboxamide
10/01/2008EP1383496B1 Treatment of fibromyalgia using pindolol
10/01/2008EP1372655B1 Cathepsin cysteine protease inhibitors
10/01/2008EP1363600B1 Liquid formulations for the prevention and treatment of mucosal diseases and disorders
10/01/2008EP1357936B1 Biocatalytic and biomimetic generation of nitric oxide in situ at substrate/blood interfaces
10/01/2008EP1355629B1 Solid phase dispersion of quinolone- or naphthyridonecarboxylic acids
10/01/2008EP1331935B1 Derivatives of tryptamine and analogous compounds, and pharmaceutical formulations containing them
10/01/2008EP1274686B1 Process for preparing 2-(4-chlorobenzolamino) -3- 2(1h) -quinolinon-4-yl proprionic acid
10/01/2008EP1251862B1 Ophthalmic compositions for treating ocular hypertension
10/01/2008EP1224160B1 Process for the preparation of the polymorphic form II of sertraline hydrochloride
10/01/2008EP1212295B1 Substituted alpha-hydroxy acid caspase inhibitors and the use thereof
10/01/2008EP1135113B1 Treatment of parkinson's disease with oligonucleotides
10/01/2008EP1131041B1 Fatty ammonium quaternary compositions
10/01/2008EP1091745B1 Treatment of hyperproliferative disorders
10/01/2008EP1047399B1 Skin care composition
10/01/2008EP0739207B1 Enteral formula with ribo-nucleotides
10/01/2008CN101278079A 药物设计方法 Drug Design Methods
10/01/2008CN101277965A N-phenyl benzamide derivatives as sirtuin modulators
10/01/2008CN101277963A Benzimidazole derivatives as SIRTUIN modulators
10/01/2008CN101277962A Bicyclic aromatic compounds useful as inhibitors of mitogen-activated protein kinase-activated protein kinase-2
10/01/2008CN101277961A Tetrahydro-pyrrolizinone compounds as LFA-1 mediators
10/01/2008CN101277960A Acylated spiropiperidine derivatives as melanocortin-4 receptor modulators
10/01/2008CN101277958A Naphthyridin derivatives
10/01/2008CN101277957A Preparation and use of tetrahydropyrrolo [3, 2-c] pyridin-4-one derivatives for treatment of obesity, psychiatric and neurological disorders
10/01/2008CN101277956A Imidazo [1,2-A] pyridine having anti-cell-proliferation activity
10/01/2008CN101277954A 8-aza-bicyclo[3.2.1]octane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
10/01/2008CN101277953A Atives of 2-aminthiazoles and 2-aminooxazoles, processes for their preparation and their use as pharmaceuticals
10/01/2008CN101277952A Isoxazole derivatives
10/01/2008CN101277951A 2-aminopyrimidine derivatives as modulators of the histamine H4 receptor activity
10/01/2008CN101277950A Inhibitors of serine proteases
10/01/2008CN101277949A Dipeptidyl peptidase-iv inhibitors
10/01/2008CN101277947A 4-(4-bromo-2-fluoroanilino)-6-methoxy-7-(l-methylpiperidin-4-ylmethoxy) quinazoline monohydrate
10/01/2008CN101277946A Heterocyclylamide-substituted thiazoles, pyrroles and thiophenes
10/01/2008CN101277942A Cytotoxin compounds and methods of isolation
10/01/2008CN101277941A Benzothiadiazolyphenylalkylamine derivatives for use in the treatment of conditions ameliorated by monoamine reuptake
10/01/2008CN101277940A 4-oxy-n-[1,3,4]-thiadiazol-2-yl-benzene sulfonamides, processes for their preparation and their use as pharmaceuticals
10/01/2008CN101277936A Process for the synthesis of compounds for selectin inhibition
10/01/2008CN101277934A Metabotropic glutamate-receptor-potentiating isoindolones
10/01/2008CN101277932A Aryl-substituted nitrogen-containing heterocyclic compound
10/01/2008CN101277930A Anti-hypercholesterolemic compounds
10/01/2008CN101277926A Method of obtaining 3,3-diphenylpropylamines
10/01/2008CN101277740A Antituberculous composition comprising oxazole compounds
10/01/2008CN101277721A Orally disintegrating tablet
10/01/2008CN101277719A Medical agent containing insulin resistance improving agent
10/01/2008CN101277713A Composition for acceleration of type I collagen production
10/01/2008CN101277709A A medical composition for treating wounds
10/01/2008CN101277705A Agent for amelioration of insulin resistance
10/01/2008CN101277704A Composition and methods of rnai therapeutics for treatment of cancer and other neovascularization diseases
10/01/2008CN101277703A Methods and compositions for treatment of viral infections
10/01/2008CN101277702A Anti mineralocorticoid therapy of infection
10/01/2008CN101277701A Pharmaceutical preparation containing meloxicam
10/01/2008CN101277700A Pyrimidine compounds as serotonin receptor modulators
10/01/2008CN101277699A Sustained-release preparation
10/01/2008CN101277698A Quinoline derivatives as antibacterial agents
10/01/2008CN101277697A Dermatitis remedies
10/01/2008CN101277696A Quinoline derivatives as antibacterial agents
10/01/2008CN101277695A Quinoline derivatives as antibacterial agents
10/01/2008CN101277694A Novel crystal forms of irinotecan hydrochloride
10/01/2008CN101277693A Use of enoxaparin for performimg percutaneous coronary intervention
10/01/2008CN101277692A Use of thiazole derivatives and analogues in the treatment of cancer
10/01/2008CN101277691A Use of a PKC activator, alone or combined with a pkc inhibitor to enhance long term memory
10/01/2008CN101277690A Abnormal protein removing composition
10/01/2008CN101277689A Thiazolopyrimidine kinase inhibitors
10/01/2008CN101277688A Formulation comprising metformin and vildagli ptin
10/01/2008CN101277687A Therapeutic agent for liver disease containing 2-amino-1,3-propanediol derivative as active ingredient and therapeutic method for liver disease
10/01/2008CN101277686A Formulations and methods for enhancing the transdermal penetration of a drug
10/01/2008CN101277685A Formulations of aica riboside
10/01/2008CN101277684A Microparticles with modified release of at least one active principle and oral galenic form comprising same
10/01/2008CN101277682A Amorphous efavirenz and production thereof
10/01/2008CN101277681A Oral solid pharmaceutical formulation of the tribulin inhibitor indibulin
10/01/2008CN101277672A Methods and compositions for reducing skin damage
10/01/2008CN101277613A Novel pharmaceutical compounds
10/01/2008CN101277612A Composition and method for use in cartilage affecting conditions
10/01/2008CN101275135A Antisense oligonucleotide for tissue-specific regulation of POKEMON gene expression and application thereof
10/01/2008CN101275134A Medicament for curing breast carcinoma and special antisense oligonucleotide therefor
10/01/2008CN101275133A DNA sequence of IER5-coded SiRNA, vector and application thereof
10/01/2008CN101275132A SiRNA capable of inhibiting influenza A virus replication and coding sequence thereof
10/01/2008CN101274953A Method for extracting corosolic acid from plant
10/01/2008CN101274934A Medicaments with HM74a receptor activity
10/01/2008CN101274932A 2-methyl-5- azomycin-1-(3-chloro-2-hydroxypropyl) chloro-substitutive derivate, preparation thereof and application thereof
10/01/2008CN101274929A Thrombin receptor antagonists
10/01/2008CN101274928A 3-substituted-4-pyrimidone derivatives
10/01/2008CN101274927A Photochemical reaction preparation for quaternary ring compound and use of the quaternary ring compound
10/01/2008CN101274926A Fluoro-and trifluoroalkyl-containing heterocyclic sulfonamide inhibitors of beta amyloid production and derivatives thereof
1 ... 3064 3065 3066 3067 3068 3069 3070 3071 3072 3073 3074 3075 3076 3077 3078 3079 3080 3081 3082 3083 3084 ... 7860